SIA
BNGO icon

SkyView Investment Advisors’s Bionano Genomics BNGO Stock Holding History

SkyView Investment Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-47
Closed -$228K – 376
2021
Q2 		$228K Hold
47
– – 0.11% 172
2021
Q1 		$228K Buy
+47
New +$265K 0.1% 180

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SkyView Investment Advisors's BNGO Position: Q3 2021 in Review

SkyView Investment Advisors sold out of Bionano Genomics (BNGO) in Q3 2021, closing a stake of 47 shares — an estimated $228K sold.

SkyView Investment Advisors first reported a position in BNGO in Q1 2021 and held it in 2 quarters. The position peaked at $228K in Q2 2021. 147 funds tracked by Wall St. Rank hold BNGO as of Q3 2021.

  • SkyView Investment Advisors reported no remaining Bionano Genomics position as of Q3 2021 after selling out during the quarter.
  • SkyView Investment Advisors sold 47 Bionano Genomics shares in Q3 2021, an estimated $228K.
  • SkyView Investment Advisors first reported a position in Bionano Genomics in Q1 2021 and held it in 2 quarters.
  • SkyView Investment Advisors's Bionano Genomics position peaked at $228K in Q2 2021.
  • 147 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2021.

Based on SkyView Investment Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.